Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm a shareholder. I went long with this. I listened too much to - "you know who". For now I'm a stuckholder. Fortunately I did not bet the farm on this because I knew that I should do my own DD and I knew that I should diversify. Nevertheless, I'm a stuckholder hoping this will resurrect from the dead. There is some element of hope, now that the SEC is behind them. But it's a crapshoot at best.
Investors Beware. Some investors can be BULLISH one second, which lures in other investors. Then turn BEARISH on a dime. Do your on DD. Here is such an example (one of many). Buyers Beware!! JMHO
----------------------------------
Dragon Lady
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164018693
Re: cjstocksup post# 4695
Tuesday, May 25, 2021 1:53:49 PM
Post# 4697 of 13723
This is HUGE for QNTA shareholders!
May 22, 2021, the registrant had 176,458,527 shares of Common Stock outstanding.
You got it cj - it's a SPECTACULAR and almost unheard of LOW and LOW FLOAT share count for any OTC company !!
And this is the final POST MERGER NUMBER - which involved a large share issuance of approx 70 million, etc.
ALL NEW MGT from the MedoLife Rx merger (now fully completed) and they made it patently clear in the newly filed SEC 10-Q of today, "WE ARE CLEANING UP LEGACY PROBLEMS left by prior mgt team" etc.
That share count could DOUBLE IN THE NEXT YR - and STILL = a mega low floater and low share count for any growth company :)
Their A/S (available share count) is set at a paltry 500 million = they do NOT plan on massive dilution going forward !
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.
This is old news. eom
Looks like JBLU is going to ALMOST hit is 'all time' low! Two years from now investors will be looking back at today price and feel sick that they didn't get in now.
I agree. They won't be able to sell shrooms to resurrect the business. Their cash balance is 3M (give or take some). So they are going to need to dilute to keep financing business operations and those salaries.
Lots of penny stocks (for lots of reasons) execute an r/s who are sitting at
356,287,674 O/S. Don't kid yourself.
I've always put RVVTF and RLFTF in the same category. Both are foreign entities (foreign to the FDA), both are tiny bitechs, neither has revenues, and both claimed to have a near-cure for COVID. So now here they are. Both are hovering between 2 and 3 cents a share. One recently had a devastating R/S, and I predict the other will have one on the near horizon.
MF is the Shroom King with misplaced priorities, and that is brought this company down. JMHO.
Uhh, News Flash.... the FDA rejected it thus far. I suspect that MF ran that PR as a pump/dump exercise which apparently failed. He needs to be creative in generating cash, and diluting at these low pps levels won't net much unless he is willing to drive the pps below a penny. I think MF is grasping at straws, and the r/s will happen out of necessity to raise cash. I have been burned in these exact situations several times, so I am speaking as a wounded warrior who had learned my lesson years ago. Never fall in love with a stock!!
Reverse Split TONIGHT (1 for 6). To avoid getting delisted. Ugly stuff!!!!!
Universe Pharmaceuticals INC Announces Share Consolidation
PDF Version
Jiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of six (6) ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one (1) ordinary share with par value of US$0.01875 (the “Share Consolidation”). As a result of the Share Consolidation, each six (6) pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders.
The Share Consolidation will be effective at 5:00 p.m. Cayman Islands time on July 27, 2023. Beginning with the opening of trading on July 28, 2023, U.S. Eastern time, the Company’s ordinary shares will begin trading on a post-Share Consolidation basis on the Nasdaq Global Market under the same symbol “UPC” but under a new CUSIP number of G9442G 112. No fractional shares will be issued in connection with the Share Consolidation. All fractional shares will be rounded up to the whole number of shares. Immediately following the Share Consolidation, the authorized share capital of the Company will be US$3,125,000 divided into 150,000,000 ordinary shares, par value $0.01875 per share and 16,666,666.6666 preferred shares, par value $0.01875 per share.
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The Company also distributes and sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold in 30 provinces of China. For more information, visit the company’s website at http://www.universe-pharmacy.com/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” ”anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.
For more information, please contact:
Investor Relations Contact:
Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com
Primary Logo
Source: Universe Pharmaceuticals INC
Have you taken notice that people are not dying from covid east cost to west coast (USA0) anymore. That only happened with Delta, and has significantly dropped off with the variants so much so that Joe B. declared an end to the COVID emergency. I think that the news has been out on that for quite some time. Maybe you missed it.
For the most part, FDA rules pertaining to EUA on covid treatments are back to pre-covid standards. RVVTF completley missed the boat on covid due to MF's obsession with Shrooms. I predict an r/s will soon be on the burner because MF needs more $ to finance his comp package. The guy is a phony.
White Choc.... I agree. At least 2 years ago multiple leading scientists announced that 'historically' viruses become weaker and weaker as they mutate over time. Hence, all of the talk about how the delta virus will eventually mutate and be treated as a common winter flu. This is exactly what happened.
And.... over that period of time standard of care (SOC) continued to improve. So biotech therapies during their FDA studies were constantly competing against improving SOC. IMO it was improving SOC is what took the legs out of most biotech FDA covid studies. As far as I could tell, most FDA studies for covid did not 100% decouple their primary endpoints from SOC. Investors who made a lot of $$ on the covid biotech sector did so by selling 'on the hype'. Those that lost $$ typically were those that held their shares down to the end (FDA trial completions).
Now RVVTF must dump/dilute more shares to keep paying their high compensation packages. The O/S and float will continue to grow. I now only see one undesirable outcome for this when MF and other officers realize that they need to re-energize this cash cow machine while they continue to pursue the DREAM of actually generating sales from a real product. Shroom sales just won't cut it IMO.
The patents are not worthless.
The patents are real, so it's not a scam.
Agreed! TSOI is not a scam. It's a very early stage biotech that happens to have a grossly high O/S and Float. Which makes it ripe for an R/S.... even though Tim has sworn that he'd never do it on his watch. Well...what if he sells the company or dies. Then that puts it under someone else's watch. Clock is Ticking. Maybe 2024 will be the year for investors. This is a long shot.
White.... you assessment is "Spot On".
Sure, after a 1 for 250 R/S. This is what cash strapped penny stocks do to survive who do not have any revenues (sales).
RVVTF has 356 million in O/S and only 2.5M in cash. They are going to need cash. Everyone knows that MF and his insider buddies will never freeze their compensation packages in order to cut the cash burn rate. Diluting to raise cash at these low PPS levels will not cut it. And I doubt MF will take on new fresh debt to pay the bills. FDA success would have bailed them out with a higher PPS to dilute. So unfortunately I predict a nasty R/S in the near future. It is what it is. JMHO
I don't believe RLFFD is the correct symbol anymore. Should be RLFTF. I'll PM IHUB
I'm not bashing, but their most recent 8K also announces that they plan on doing a boat load more dilution. Which will surely put downward pressure on the PPS. What puzzles me is they roughly have 2x their debt is cash (per Yahoo Finaince). So why not use the cash to pay off the debt. There is clearly some sort of cashflow problem. Here is an excerpt from the recent 8K......
On June 22, 2023, Virgin Galactic Holdings, Inc. (the “Company”) entered into a distribution agency agreement (the “Distribution Agency Agreement”) with Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (each, an “Agent” and collectively, the “Agents”) providing for the offer and sale of up to $400,000,000 of shares of the Company’s common stock, par value $0.0001 per share, from time to time by the Company through the Agents, acting as the Company’s sales agents, or directly to one or more of the Agents, acting as principal.
How long is long though. Here is Barron's view. They predict that it will take 7 years before this company will break even.. That's a long time to wait, and lot of things can happen between now and then.
----------Barron's
The problem is that analysts don’t project positive free cash flow until near the end of the decade when annual sales are projected to be north of $700 million. Sales in 2023 are expected to be about $11 million.
Could be a short squeeze, unless it becomes a very short flight.
Looks like you may be right. I found this on Space.com They claim to broadcast it on their site.
https://www.space.com/virgin-galactic-first-commercial-mission-importance
I found this....
Events will begin at 11 a.m. EDT (1600 GMT, or 9 a.m. local time in New Mexico) on June 29. The mission will launch from New Mexico's Spaceport America, where Virgin Galactic hosts a commercial hub.
The media always sensationalizes things.
Virgin Galactic stock surging today after announcing that its first commercial spaceflight will take off tomorrow
https://finance.yahoo.com/video/virgin-galactic-stock-rises-ahead-154708879.html
A three-man crew from Italy is set on Thursday
Virgin Galactic set to launch its first commercial rocket plane spaceflight
https://finance.yahoo.com/news/virgin-galactic-set-launch-first-142354325.html
I'm surprised that GEM went along with the R/S strategy. No NASDAQ uplisting in sight. Most reverse splits use that lame excuse to keep the SH at aby, and then never deliver. We'll see what happens here.
Unfortunately, once they do one R/S....it's very easy to do another, and another. So if the pps drifts down to a buck (from dilution) I predict another R/S.
Some very powerful good news is needed to resurrect this dog. ACER has a $1M cash infusion now, so maybe they will get the show on the road with generating revenues soon.
Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
https://finance.yahoo.com/news/acer-therapeutics-receives-1-million-123000673.html
Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
This should be good for RLFTF.
https://finance.yahoo.com/news/acer-therapeutics-receives-1-million-123000673.html
4 Hot Penny Stocks Making Waves : ALKM, FBCD, RMHI, RLFTF June 23, 2023
https://www.drpjournal.com/4-hot-penny-stocks-making-waves-alkm-stgz-fbcd-rmhi/
Affirmative!
It's about time!!! Their compensation packages should be frozen until they can start to generate sales of some sort. Their priorities are all backwards. RAM should be fired and replaced with someone who understands how to balance sales and marketing with R&D.
Of it is corrupt! They take bribes by way of the PDUFA fees. Unfortunately the government has enabled them to become corrupt.... all legal. Just unethical. That is our politicians at work! I'm sure that there are some political kickbacks in there buried somewhere.
Want proof. How about undercover operation on tape. Here is the link. Scroll to the bottom and watch Part 1 and Part 2. https://www.projectveritas.com/
No news. Just an imbalance in supply and demand.
Any idea what is causing the price spike today? I can't find any news on it.
not a clue. they stopped communicating matters of interest to the SH. I’ve always felt that the nasdaq talk was gibberish that penny stock ceo’s always say to appease SH before a devastating R/S. And they never shared with the SH their final analysis of the trial data that NRX was forced to give them. off the radar.
More dilution....The management salaries and bonus checks must be paid on the backs of the SH. Someday the fat cats will start doing their job and find a way to generate sales.
"..... Relief Therapeutics plans to use the net proceeds from the private placement for working capital and other general corporate purposes."
https://finance.yahoo.com/news/relief-therapeutics-holding-sa-announces-053000386.html
Here is the full items up for vote......... #8 looks like a R/S
I received the proxy to vote on this items TODAY.
https://www.sec.gov/Archives/edgar/data/1809616/000121390023042704/f6k0523ex99-1_universe.htm
This looks like a R/S in their proxy to be be voted on..... is it not ???
As ordinary resolutions, that: conditional upon the approval of the Board of Directors in its sole discretion, with effect as of the date the Board of Directors of the Company may determine: a. authorized, issued and outstanding shares of the Company (collectively, the "Shares") be consolidated by consolidating each 10 Shares of the Company, or such lesser whole share amount as the Board of Directors may determine in its sole discretion, such amount not to be less than 2, into 1 Share of the Company with such consolidated Shares having the same rights.
Acer Therapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $9.67 https://www.investorsobserver.com/news/stock-update/healthcare-stocks-moving-wednesday-pbla-chek-acer-indp-namsw-nams-carm-zlab